Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response

Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response

US Patent 10232038 · Granted Mar 19, 2019

Estimated economic value: $377,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody molecules to LAG-3 and uses thereof2025
Combined preparations for the treatment of cancer2025
Combined preparations for the treatment of cancer or infection2023
Anti-LAG-3 antibodies2023
Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immun2023
Combined preparations for the treatment of cancer or infection2021
Combined preparations for the treatment of cancer or infection2020
Combined preparations for the treatment of cancer2020
Antibody molecules to LAG-3 and uses thereof2020
Antibody molecules to LAG-3 and uses thereof2018
Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immun2017
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevent2016